Prices to be printed on all prescribed NHS drugs over £20
July 2, 2015Manufacturing and Production, Medical Communications, Sales and Marketing Jeremy Hunt, NHS, UK, drugs, health secretary, medicines
NHS drugs costing more than £20 will, from next year, have the price and the words “funded by the UK …
Boehringer Ingelheim launches Spiolto for COPD
July 2, 2015Sales and Marketing Boehringer Ingelheim, COPD, Europe, Spiolto, Spiriva, Striverdi
Boehringer Ingelheim is beginning a new push in lung disease across Europe after being approved by regulators in nine countries …
Pharma outsourcing: CROs, CMOs and external collaboration
July 2, 2015Manufacturing and Production, Research and Development CMOs, R&D, clinical trials, collaboration, cros, outsourcing
Thirty years ago pharma companies seemed to use external contractors as a sort of fire brigade, to be called in …
Mission Therapeutics appoints Dr Colin Goddard to its board of directors
July 2, 2015Research and Development Colin Goddard, Mission Therapeutics, appointments
MISSION Therapeutics, a drug discovery and development company today has appointed Dr Colin Goddard, former chief executive of OSI Pharmaceuticals, …
Opdivo launched in the UK for skin cancer
July 2, 2015Sales and Marketing BMS, Bristol-Myers Squibb, EMA, Early Access to Medicines Scheme, MHRA, eams, melanoma, opdivo, skin cancer
Bristol-Myers Squibb has launched its cancer immunotherapy treatment Opdivo in the UK for patients with advanced skin cancer. Opdivo (nivolumab) …
DJM Unlimited makes new director appointment
July 1, 2015Medical Communications DJM Unlimited, Michael Le Brocq
UK and US based company DJM Unlimited has appointed Michael Le Brocq as board director. Le Brocq has 20 years’ …
Pfizer partners with NIHR to boosts UK R&D
July 1, 2015Research and Development Manchester, NIHR, Pfizer, R&D, Sally Davies
Pfizer has signed an agreement with the National Institute for Health Research Clinical Research Network to conduct more clinical research …
Novartis launches ViaOpta Apple Watch app
July 1, 2015Medical Communications Novartis, apple watch, apps, visual impairment, wearables
Novartis has launched new features of its ViaOpta app for use with the Apple Watch and other wearable devices. The …
Boehringer and Vitae Pharma drug fails in mid-stage trial
July 1, 2015Research and Development BI, Boehringer, Boehringer Ingelheim, Vitae Pharmaceuticals, diabetes, type 2 diabetes
A pipeline diabetes drug co-developed by Vitae Pharma and German giants Boehringer Ingelheim has failed to show benefits in a …
FDA sued over failure to disclose Sovaldi data
June 30, 2015Sales and Marketing FDA, Gilead, hepatitis C, sofosbuvir, sovaldi
Two groups that campaign for wider access to medicines have filed a lawsuit against the FDA, in a bid to …
Celgene enters 10-year $1 billion pact with Juno
June 30, 2015Research and Development, Sales and Marketing CAR-T, Celgene, Chimeric Antigen Receptor Technology, Juno, T Cell Receptor, TCR, brett wells
Celgene has invested $1 billion into Juno Therapeutics as part of a 10-year partnership aiming to study cures for cancer …
BMS’ Opdivo accepted to UK early access scheme
June 30, 2015Sales and Marketing BMS, Cancer, NSCLC, eams, keytruda, opdivo
Bristol-Myers Squibb has scored another first with its new-generation oncology therapy Opdivo, which has become the first lung cancer drug …
The Partners hires creative director from InVentive
June 30, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Novo Nordisk, The International Aids Society, The partners, inventive, peter henshaw
Brand consultancy The Partners has appointed creative director Peter Henshaw to lead its creative offerings for the agency’s health team. …
Lilly and Immunocore collaborate on melanoma
June 29, 2015Research and Development, Sales and Marketing LY2157299, LY2801653, brett wells, immunocore, lilly
Eli Lilly is teaming up again with UK biotech Immunocore in order to work together on immunotherapy-based clinical trials. Specifically …
UK pharma’s ‘Golden Triangle’ faces competition from new challengers
June 29, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BioGateway, Cambridge, London, Oxford
The UK’s medical and scientific base is regarded as one of the world’s best.
Boehringer scores trial success for Pradaxa antidote
June 29, 2015Research and Development, Sales and Marketing Boehringer, Pradaxa, idarucizumab
Bosses at Boehringer Ingelheim say the latest results of a study of idarucizumab, and antidote for its blockbuster blood-thinner Pradaxa, …
Novartis spends $200m on pain firm Spinifex
June 29, 2015Sales and Marketing Cosentyx, EMA401, Novartis, Secukinumab, spinifex
Novartis is spending $200 million to increase its presence in pain management through the purchase of US-Australian biotech Spinifex Pharmaceuticals. …
Bayer’s Eylea approved in Japan
June 29, 2015Sales and Marketing Eylea, Japan, aflibercept. bayer
German firm Bayer has been shown the green light by the Japanese Ministry of Health, Labour and Welfare to market …
Synexus announces new board
June 29, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Synexus, woler
Following a management buyout Synexus has confirmed who its new board members are to steer the UK recruitment and clinical …
EMA waves through a raft of drug recommendations
June 26, 2015Research and Development, Sales and Marketing AbbVie, Alexion, CHMP, EMA, Novartis, Novo Nordisk, brett wells
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended several treatments for marketing …
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
